Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 02, 2019

SELL
$219.29 - $241.72 $1.47 Million - $1.62 Million
-6,700 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$307.64 - $344.58 $2.06 Million - $2.31 Million
6,700
6,700 $2.13 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.6B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Advanced Asset Management Advisors Inc Portfolio

Follow Advanced Asset Management Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advanced Asset Management Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advanced Asset Management Advisors Inc with notifications on news.